Compound lycopene formulation for women and preparation process thererof

A lycopene and compound technology, which is applied in the field of compound lycopene preparations for women and its preparation, can solve the problems of unsatisfactory effects, poor stability, and low bioavailability, and achieve anti-aging, stable quality, and bioavailability high degree of effect

Inactive Publication Date: 2006-02-22
XINJIANG TEFENG PHARMA
View PDF0 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, there are lycopene, soy isoflavones, and vitamin E products on the market alone. Studies have shown that these products have poor stability, low bioavailability, and unsatisfactory effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Embodiment 1, the capsule shell of this compound lycopene soft capsule contains by weight percentage: 35% gelatin, 18% glycerol, 0.08% methyl p-hydroxybenzoate and the water of balance; The core of the capsule contains by weight: 0.1% lycopene, 50% soybean isoflavones, 30% vitamin E, 5% beeswax, 0.2% tert-butyl hydroquinone (TBHQ), and The balance of safflower oil.

Embodiment 2

[0027] Example 2, the capsule shell of the compound lycopene soft capsule contains by weight percentage: 36% gelatin, 10% glycerin, 10% sorbitol, 0.10% ethyl p-hydroxybenzoate and the rest of water; The capsule core of the compound lycopene soft capsule contains by weight percentage: 0.1% lycopene, 20% soybean isoflavones, 60% vitamin E, 5% suet, 3% glycerin, 1.5% tea polyphenols, and seabuckthorn oil in the balance.

Embodiment 3

[0028] Embodiment 3, the capsule shell of this compound lycopene soft capsule contains by weight percentage: 37% gelatin, 22% sorbitol, 0.11 methyl p-hydroxybenzoate, 0.35% tartrazine, 0.07% ethyl Vanillin, 1% titanium dioxide and water in the balance; the capsule core of the compound lycopene soft capsule contains by weight percentage: 0.1% lycopene, 30% soybean isoflavones, 0.1% vitamin E, 10 % glycerin, 5% polyethylene glycol monostearate, 1% butylated hydroxyanisole (BHA), 6% tea oil, and the salad oil of the remainder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Disclosed is a compound tomatine preparation for female and its preparing process, wherein the preparation comprises tomatine, soybean isoflavones, vitamin E, anti-oxidant, capsule stabilizing agent and balancing deflocculating agent. The preparation can be made into the dosage forms of soft capsules, tablets or oral liquids.

Description

technical field [0001] The invention relates to a medical preparation and a production method thereof, which is a compound lycopene preparation for women and a preparation process thereof. The compound lycopene preparation for women can effectively improve the estrogen level in the body and remove excessive free radicals in the body. Background technique [0002] Studies have found that when women reach a certain age, their physiological characteristics will undergo some changes, such as: decreased estrogen secretion, decreased ability to scavenge free radicals in the body, and so on. These changes reduce the quality of life of women, accelerate the aging of women, and even lead to the occurrence of diseases. [0003] The reduction of estrogen level can reduce bone density: it can cause osteoporosis; it can easily lead to autonomic nervous system dysfunction, such as irritability, insomnia, cardiovascular dysfunction, memory loss and other sympt...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/557A61K9/48A61P5/30A61P39/06A61K31/352A61K31/355
Inventor 陶亮云琦冯崴朱金芳崔阿旎
Owner XINJIANG TEFENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products